Eli Lilly and Company LLY announced that the FDA has granted approval to its drug, Omvoh (mirikizumab), for its second inflammatory bowel disease (IBD) condition, Crohn's disease (“CD”), in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback